comparemela.com
  1. Home
  2. Live Updates
  3. Hemosensitivity - Breaking News

Latest Breaking News On - Hemosensitivity - Page 1 : comparemela.com

Agendia, Inc : Agendia Research Shows Highest Risk MammaPrint Category Predicts Strongest Chemosensitivity in Women with Early-Stage HR+HER2- Breast Cancer

At the 2023 ASCO® Annual Meeting, Agendia will present data that demonstrates women within MammaPrint's highest risk category have the strongest sensitivity to chemotherapy and more aggressive tumor

United statesKerry harringtonWilliam audehPeter beitschAgendia mammaprintDallas surgical groupAgendia incAnnual meetingHigh riskUltra lowChief medical officerPrint indexMammaprint high riskSurgical oncologistDallas surgicalMammaprint high

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.